Market Overview and Recent Performance of Laobaixing Pharmacy Chain
Laobaixing Pharmacy Chain (603883.SS) closed the trading session of Wednesday, 21 April 2026, unchanged at CNY 14.67 per share, representing a 0 % change over the preceding 24 hours. The stock’s trading volume in that period amounted to approximately CNY 358 million, while the overall circulating supply remains at 730.3 million shares.
With a market capitalisation of CNY 10.8 billion, Laobaixing Pharmacy Chain has exhibited a notable upward trajectory, rising 14.29 % since the end of March. Its 200‑day simple moving average is currently at CNY 12.58, indicating a sustained upward trend over the longer term. The company’s most recent 52‑week high was CNY 17.96 on 14 November 2025, whereas the low reached CNY 10.67 on 29 June 2026.
Comparative Analysis with Peer Stocks
| Stock | 24‑hour Change | Current Price | Market Capitalisation | P/E Ratio |
|---|---|---|---|---|
| Guangdong Ellington Electr (603328.SS) | Flat 0 % | CNY 13.18 | CNY 12.8 bn | 41.92 |
| Poly Property Services‑H (6049.HK) | +1.26 % | HKD 27 | HKD 15.1 bn | 8.04 |
| Wuxi Rural Commercial Bank (600908.SS) | Flat 0 % | CNY 5.89 | CNY 12.9 bn | 5.85 |
| Luenmei Quantum (600167.SS) | Flat 0 % | CNY 5.36 | CNY 12.8 bn | 23.32 |
| Hainan Strait Shipping (002320.SZ) | Flat 0 % | CNY 5.74 | CNY 12.9 bn | 70.59 |
Laobaixing Pharmacy Chain’s stability in the short term contrasts with the modest gains of Poly Property Services‑H and the flat performance of its peers, reflecting differing investor sentiment across sectors.
Company Profile
Laobaixing Pharmacy Chain JSC, headquartered in Changsha, China, specialises in the retail and distribution of medical products. Its inventory encompasses Chinese herbal medicines, antibiotic preparations, biochemical drugs, and ancillary medical equipment. The company is listed on the Shanghai Stock Exchange and maintains an online presence at www.lbxdrugs.com , where detailed product information and corporate disclosures can be accessed.
This article provides a concise snapshot of Laobaixing Pharmacy Chain’s recent market activity, its relative standing among peer securities, and a brief overview of its core business operations.